Lashuel lab

The Lashuel laboratory at EPFL is now closed.

The Lashuel lab at EPFL is now closed. The exciting science goes on! Prof Hilal Lashuel has recently taken a position as Executive Director of Research Development and Innovation (RDI) at the Qatar Fundation & RDI Advisor to the Chairperson of Qatar Foundation.

Latest news

©EPFL/iStock photos (koto_feja)

Protein modifications key influencers in neurodegenerative diseases

— Exploring the post-translational modifications of a key protein in Parkinson's disease, researchers at EPFL and USC uncover potential pathways for future therapies in neurodegenerative diseases in general.

© EPFL/iStock photos

AI unlocks new insights in neurodegenerative disease research

— EPFL researchers develop an AI-driven, label-free method for studying protein aggregates, offering new perspectives in neurodegenerative disease research.

Pathological phosphorylation (yellow) of Tau proteins (red-orange) leads to disintegration of microtubules in the neuron axon. (iStock photos)

ClearTau: a new tool for studying neurodegenerative diseases

— EPFL scientists have developed ClearTau, an innovative method and platform for reconstructing aggregates of the protein Tau found in Alzheimer’s disease and other neurodegenerative diseases. The breakthrough can speed up the development of diagnostics and targeted therapies for Tau-related disorders.

All news